ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

Situations that may arise with CML during pregnancy & management strategies

Автор: VJHemOnc – Video Journal of Hematology & HemOnc

Загружено: 2023-10-12

Просмотров: 151

Описание: Elisabetta Abruzzese, MD, PhD, S. Eugenio University Hospital, Rome, Italy, discusses various situations that may arise with chronic myeloid leukemia (CML) during pregnancy. Dr Abruzzese comments on how to approach patients who discover CML during pregnancy and patients who become pregnant while already having established disease, and further summarizes appropriate treatment strategies for each of these scenarios. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Situations that may arise with CML during pregnancy & management strategies

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

The importance of tailoring treatments to subtypes of PTCL

The importance of tailoring treatments to subtypes of PTCL

Phase Ib study of bleximenib plus venetoclax in AML with KMT2A or NPM1 alterations

Phase Ib study of bleximenib plus venetoclax in AML with KMT2A or NPM1 alterations

Sanktuarium Matki Bożej Chełmskiej

Sanktuarium Matki Bożej Chełmskiej

"Oczekiwania z kosmosu". Młodzi odpuszczają związki

Can JAK2V617F VAF variations help predict clinical and survival outcomes?

Can JAK2V617F VAF variations help predict clinical and survival outcomes?

Why 95% of Healthcare AI Fails and How Post-Acute Care Can Scale Automation That Works [INOvators]

Why 95% of Healthcare AI Fails and How Post-Acute Care Can Scale Automation That Works [INOvators]

Konferencja marszałka Sejmu Włodzimierza Czarzastego

Konferencja marszałka Sejmu Włodzimierza Czarzastego

The clinical use of circulating tumor DNA in T-cell lymphomas

The clinical use of circulating tumor DNA in T-cell lymphomas

To koniec dla Ukrainy? / Paraliż państwa / Nagły apel Zełenskiego

To koniec dla Ukrainy? / Paraliż państwa / Nagły apel Zełenskiego

The evolving landscape of infrastructure investment

The evolving landscape of infrastructure investment

ASH 2025 Expert Insights: Early Cilta-Cel Transforms Treatment for Multiple Myeloma

ASH 2025 Expert Insights: Early Cilta-Cel Transforms Treatment for Multiple Myeloma

„Środowisko wariackie”- Bosak uderza w ludzi Brauna.Trump dostanie Nobla? Kto przejmie dane z KSeF?

„Środowisko wariackie”- Bosak uderza w ludzi Brauna.Trump dostanie Nobla? Kto przejmie dane z KSeF?

Geriatric assessment-guided treatment in older AML: cognitive and functional predictors

Geriatric assessment-guided treatment in older AML: cognitive and functional predictors

Should JAK2 VAF testing be implemented as routine in risk assessment and disease monitoring in MPN?

Should JAK2 VAF testing be implemented as routine in risk assessment and disease monitoring in MPN?

40 g dziennie i dzieje się MAGIA w wątrobie.

40 g dziennie i dzieje się MAGIA w wątrobie.

ASH 2025 Expert Insights: CAR-T Expansion & Delayed Neurotoxicity in Multiple Myeloma

ASH 2025 Expert Insights: CAR-T Expansion & Delayed Neurotoxicity in Multiple Myeloma

Fedorska: Niemiecki przemysł chemiczny zostanie WYŁĄCZONY! Magazyny gazu u sąsiada świecą PUSTKAMI

Fedorska: Niemiecki przemysł chemiczny zostanie WYŁĄCZONY! Magazyny gazu u sąsiada świecą PUSTKAMI

Why is myeloma so unique? National myeloma month 2023

Why is myeloma so unique? National myeloma month 2023

Drivers of racial and ethnic disparities in access to frontline CLL therapy in the US

Drivers of racial and ethnic disparities in access to frontline CLL therapy in the US

ASH 2025 Expert Insights: VSA012 siRNA Shows Promise for PNH

ASH 2025 Expert Insights: VSA012 siRNA Shows Promise for PNH

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]